Arcturus Therapeutics Holdings Inc Inc. (ARCT) Price Performance: A Technical Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 47.35%. However, over the last six months, the performance has been stronger by -6.51%. The price of ARCT increased 21.31% over the last 30 days. And in the last five days, it has surged by 30.43%.

Arcturus Therapeutics Holdings Inc (ARCT) current stock price is $24.99. During the last trading session, the stock soared, reaching $25.38 after opening at $22.74. The stock’s lowest point was $22.595 before it closed at $22.18.

Arcturus Therapeutics Holdings Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $37.75 on 07/19/23, and the lowest price during that time was $14.21, recorded on 03/10/23.

52-week price history of ARCT Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Arcturus Therapeutics Holdings Inc’s current trading price is -33.80% away from its 52-week high, while its distance from the 52-week low is 75.86%. The stock’s price range for this period has been between $14.21 and $37.75. The Healthcare sector company’s shares saw a trading volume of about 0.66 million for the day, which was higher than the average daily volume of 0.38 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Arcturus Therapeutics Holdings Inc (ARCT) has experienced a quarterly decline of -19.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 667.73M and boasts a workforce of 170 employees.

Expert Opinions: Analysts’ Ratings for Arcturus Therapeutics Holdings Inc

As of right now, 7 analysts are rating Arcturus Therapeutics Holdings Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 27.42, with a change in price of -1.00. Similarly, Arcturus Therapeutics Holdings Inc recorded 427,279 in trading volume during the last 100 days, posting a change of -3.85%.

ARCT’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ARCT stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.17.

ARCT Stock Stochastic Average

As of today, the raw stochastic average of Arcturus Therapeutics Holdings Inc over the past 50 days is 49.75%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 83.18%. Additionally, the Stochastic %K and %D values for the company were 63.59% and 48.21%, respectively, over the past 20 days.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts